BLFS:NSC-BioLife Solutions Inc. (USD)

EQUITY | Medical Instruments & Supplies | NASDAQ Capital Market

Last Closing

USD 21.43

Change

+0.93 (+4.54)%

Market Cap

USD 0.02B

Volume

0.55M

Analyst Target

USD 26.08
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
ISRG Intuitive Surgical Inc

N/A

USD 170.28B
COO The Cooper Companies, Inc. Com..

N/A

USD 21.88B
ALGN Align Technology Inc

N/A

USD 19.03B
HOLX Hologic Inc

N/A

USD 18.77B
RGEN Repligen Corporation

N/A

USD 8.24B
MMSI Merit Medical Systems Inc

N/A

USD 5.69B
XRAY Dentsply Sirona Inc

N/A

USD 5.48B
ICUI ICU Medical Inc

N/A

USD 4.26B
AZTA Azenta Inc

N/A

USD 2.42B
LMAT LeMaitre Vascular Inc

N/A

USD 2.06B

ETFs Containing BLFS

PZI 0.00 % 0.70 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange (NASDAQ Capital Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 31.88% 88% B+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.88% 88% B+ 88% B+
Trailing 12 Months  
Capital Gain -3.03% 70% C- 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.03% 70% C- 47% F
Trailing 5 Years  
Capital Gain 26.43% 68% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.43% 68% D+ 64% D
Average Annual (5 Year Horizon)  
Capital Gain 24.84% 79% B- 82% B
Dividend Return 24.84% 79% B- 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 84.75% 23% F 19% F
Risk Adjusted Return 29.31% 70% C- 63% D
Market Capitalization 0.02B 75% C 72% C

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Instruments & Supplies) Ratio vs. Market (NASDAQ Capital Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 185.00 15% 6%
Price/Book Ratio 2.21 60% 44%
Price / Cash Flow Ratio -75.32 95% 96%
Price/Free Cash Flow Ratio -16.28 92% 88%
Management Effectiveness  
Return on Equity -18.20% 52% 46%
Return on Invested Capital -81.56% 21% 15%
Return on Assets -8.04% 49% 37%
Debt to Equity Ratio 5.42% 90% 76%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector